Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-27

Clinical Trial Update: Possibilities of Recording Changes in Various Health Parameters by Measuring Bioimpedance With the mBCA 555 During the Use of Products From the L112 Product Range

View source ↗

Summary

This completed trial explored whether bioimpedance measurements using the mBCA 555 can detect changes in health parameters during use of Certmedica's L112 produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L112 product range

Snippet

Sponsor: Certmedica International GmbH | Conditions: Overweight | Status: COMPLETED